The table below shows Oruka Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
$0.00
$0.00
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$100.64M
$75.06M
$1.01M
$4.75M
$13.83M
$4.99M
SG&A
-
ORKA annual revenue (10-K history)
Oruka Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2023. Figures come from the company's audited annual reports as filed with the SEC.